메뉴 건너뛰기




Volumn 14, Issue 2, 2006, Pages 71-72

Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppresive agents

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

EID: 33645782033     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940600674368     Document Type: Editorial
Times cited : (26)

References (4)
  • 2
    • 0035025345 scopus 로고    scopus 로고
    • Revised diagnostic criteria for Vogt-Koyanagi-Harada Disease: Report of an international committee on nomenclature
    • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada Disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647-652.
    • (2001) Am J Ophthalmol , vol.131 , pp. 647-652
    • Read, R.W.1    Holland, G.N.2    Rao, N.A.3
  • 3
    • 33645768416 scopus 로고    scopus 로고
    • Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first line therapy
    • Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first line therapy. Ocul Immunol Inflamm. 2006;14:87-90.
    • (2006) Ocul Immunol Inflamm , vol.14 , pp. 87-90
    • Paredes, I.1    Ahmed, M.2    Foster, C.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.